Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Medullary thyroid cancer in the patient or a close relative is one, as is multiple endocrine neoplasia type 2
The FDA added delayed gastric emptying to the label
It is a GLP-1 receptor agonist and the active ingredient in Saxenda, a prescription injectable for weight-related concerns
Nguyen BA, Alexander MR, Harrison DG
The FDA has issued public warnings about dosing errors and adverse events involving compounded semaglutide and tirzepatide - with more than 1,700 adverse events linked to compounded semaglutide and tirzepatide combined as of May 21, 2026, according to FDA's published adverse event data
US$ 26.10
US$ 27.11
US$ 25.24
US$ 20.49
US$ 23.01
US$ 29.37
